chr1-108929794-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP3BP4BS1_Supporting
The NM_013296.5(GPSM2):c.1909C>T(p.Arg637Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000657 in 1,613,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_013296.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPSM2 | NM_013296.5 | c.1909C>T | p.Arg637Trp | missense_variant | 15/15 | ENST00000264126.9 | NP_037428.3 | |
CLCC1 | NM_001377458.1 | c.*2753G>A | 3_prime_UTR_variant | 13/13 | ENST00000369969.7 | NP_001364387.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPSM2 | ENST00000264126.9 | c.1909C>T | p.Arg637Trp | missense_variant | 15/15 | 1 | NM_013296.5 | ENSP00000264126 | P1 | |
CLCC1 | ENST00000369969.7 | c.*2753G>A | 3_prime_UTR_variant | 13/13 | 5 | NM_001377458.1 | ENSP00000358986 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000167 AC: 42AN: 251188Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135782
GnomAD4 exome AF: 0.0000623 AC: 91AN: 1461558Hom.: 0 Cov.: 30 AF XY: 0.0000564 AC XY: 41AN XY: 727082
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74424
ClinVar
Submissions by phenotype
Chudley-McCullough syndrome Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 06, 2024 | Identified in patients with pituitary stalk interruption syndrome who also harbored additional potentially pathogenic variants in other genes in published literature (PMID: 32864857); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 32864857) - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 24, 2023 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jun 30, 2015 | - - |
GPSM2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 15, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at